China CDE Q&A on DMF Filing and Drug Application’s Electronic Submission (Mar 3rd 2023)
China Center for Drug Evaluation (CDE) published six questions and answers on 3rd Mar. The Q&As are regarding drug master file (China DMF) filing (Q1-Q2) and electronic submissions for drug applications (Q3-Q6). Accestra provided English translations of the Q&As. In the event of any inconsistencies between the translated text and the original Chinese version, the […]